ArticleF1000 medicine reports2012
Neuromodulation for treatment-resistant depression.
Article in F1000 medicine reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT05845164 (Impulsivity Mediation Using Transcranial Direct Current Stimulation Paired With Acceptance Commitment Therapy as an Adjunctive Therapy for Substance Use Disorder), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Impulsivity Mediation Using Transcranial Direct Current Stimulation Paired With Acceptance Commitment Therapy as an Adjunctive Therapy for Substance Use Disorder
Who cites it
15 citing papers in PubMed.
- The Rate and Risk Factors of Deep Brain Stimulation-Associated Complications: A Single-Center Experience.Operative neurosurgery (Hagerstown, Md.) · 2025Article
- Research on treatment-related aspects of depression from India in the preceding decade (2014-2023): An updated systematic review.Indian journal of psychiatry · 2023Review
- Combinatorial approaches for treating neuropsychiatric social impairment.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022Review
- Changes in pallidal neural activity following long-term symptom improvement from botulinum toxin treatment in DYT6 dystonia: a case report.Journal of medical case reports · 2022Article
- Neuroprotective Effects and Therapeutic Potential of Transcorneal Electrical Stimulation for Depression.Cells · 2021Review
- A Decade of Progress in Deep Brain Stimulation of the Subcallosal Cingulate for the Treatment of Depression.Journal of clinical medicine · 2020Review
- Individual-specific functional connectivity of the amygdala: A substrate for precision psychiatry.Proceedings of the National Academy of Sciences of the United States of America · 2020Article
- The tenacious brain: How the anterior mid-cingulate contributes to achieving goals.Cortex; a journal devoted to the study of the nervous system and behavior · 2020Review
- Remote Stimulation of Sciatic Nerve Using Cuff Electrodes and Implanted Diodes.Micromachines · 2018Article
- Response rate profiles for major depressive disorder: Characterizing early response and longitudinal nonresponse.Depression and anxiety · 2018Article
- BDNF-Dependent Effects on Amygdala-Cortical Circuitry and Depression Risk in Children and Youth.Cerebral cortex (New York, N.Y. : 1991) · 2018Article
- Acute and repetitive fronto-cerebellar tDCS stimulation improves mood in non-depressed participants.Experimental brain research · 2018Article
- Network effects of deep brain stimulation.Journal of neurophysiology · 2015Review
- Multimodal approaches to define network oscillations in depression.Biological psychiatry · 2015Review
- Adverse events associated with deep brain stimulation for movement disorders: analysis of 510 consecutive cases.Neurosurgery · 2015Article
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical stimulation, and deep brain stimulation among others. Of these, only two (transcranial magnetic stimulation and vagus nerve stimulation) currently have US Food and Drug Administration approval for the treatment of depression.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.